a.Many types of viruses can cause common colds.
b.Interferon causes people’s noses to become stuffy.
c.Interferon has a high potential for preventing colds.
d.Common colds cause much more misery than other diseases.
ตอบ d.
2)Direction : Read the following passages and choose the best answer for each item.
The common cold probably causes more misery to more people than any other viral infection. Researchers have now found that it is possible to stop the spread of colds – at least within families.
Several recent studies have shown that alpha 2 interferon sprayed into the nose protects against colds, especially those caused by a class of viruses called rhinoviruses. Unfortunately, after a couple of weeks the treatment also causes many people’s noses to become dry, stuffy and bloody.
In a new clinical trial, researchers led by Robert Douglas at the University of Adelaide, and Frederick Hayden and his colleagues at the University of Virginia, found that spraying interferon into the nose once a day for a week could keep colds away in the short time, with only an occasional case of mild nasal bleeding.
Both groups of researchers tested the spray on the people most vulnerable to catching colds-those living with someone who had just come down with an infection. The Australian group found that only 14 percent of the interferon users showed cold symptoms. This result was confirmed by testing patients’ nose and throat swabs for the presence of virus. The American researchers found that only 7 percent of people treated with interferon fell ill during the trial period, but 35 percent of people using placebos became ill.
To find out how long the protection lasts, they assessed the incidence of colds in the two weeks following treatment. Only 1.3 percent of the people who used the drug developed colds that could be confirmed in laboratory. Fifteen percent of those on placebos succumbed.
Interferon is made in the form of a …………….
a.pill
b.cream
c.liquid
d.powder ตอบ c
3)Direction : Read the following passages and choose the best answer for each item.
The common cold probably causes more misery to more people than any other viral infection. Researchers have now found that it is possible to stop the spread of colds – at least within families.
Several recent studies have shown that alpha 2 interferon sprayed into the nose protects against colds, especially those caused by a class of viruses called rhinoviruses. Unfortunately, after a couple of weeks the treatment also causes many people’s noses to become dry, stuffy and bloody.
In a new clinical trial, researchers led by Robert Douglas at the University of Adelaide, and Frederick Hayden and his colleagues at the University of Virginia, found that spraying interferon into the nose once a day for a week could keep colds away in the short time, with only an occasional case of mild nasal bleeding.
Both groups of researchers tested the spray on the people most vulnerable to catching colds-those living with someone who had just come down with an infection. The Australian group found that only 14 percent of the interferon users showed cold symptoms. This result was confirmed by testing patients’ nose and throat swabs for the presence of virus. The American researchers found that only 7 percent of people treated with interferon fell ill during the trial period, but 35 percent of people using placebos became ill.
To find out how long the protection lasts, they assessed the incidence of colds in the two weeks following treatment. Only 1.3 percent of the people who used the drug developed colds that could be confirmed in laboratory. Fifteen percent of those on placebos succumbed.
What is a disadvantage of using interferon?
a.It causes the patient’s nose to bleed.
b.It results in serious infections.
c.It irritates the user’s throat and mouth
d.It leads to other diseases of the nose. ตอบ d
4)Direction : Read the following passages and choose the best answer for each item.
The common cold probably causes more misery to more people than any other viral infection. Researchers have now found that it is possible to stop the spread of colds – at least within families.
Several recent studies have shown that alpha 2 interferon sprayed into the nose protects against colds, especially those caused by a class of viruses called rhinoviruses. Unfortunately, after a couple of weeks the treatment also causes many people’s noses to become dry, stuffy and bloody.
In a new clinical trial, researchers led by Robert Douglas at the University of Adelaide, and Frederick Hayden and his colleagues at the University of Virginia, found that spraying interferon into the nose once a day for a week could keep colds away in the short time, with only an occasional case of mild nasal bleeding.
Both groups of researchers tested the spray on the people most vulnerable to catching colds-those living with someone who had just come down with an infection. The Australian group found that only 14 percent of the interferon users showed cold symptoms. This result was confirmed by testing patients’ nose and throat swabs for the presence of virus. The American researchers found that only 7 percent of people treated with interferon fell ill during the trial period, but 35 percent of people using placebos became ill.
To find out how long the protection lasts, they assessed the incidence of colds in the two weeks following treatment. Only 1.3 percent of the people who used the drug developed colds that could be confirmed in laboratory. Fifteen percent of those on placebos succumbed.
From the studies, the number of people catching colds in the Australian group is …….
a.one-third of that in the American group
b.as great as that in the American group
c.much less than that in the American group
d.twice as great as that in the American group ตอบ d
5)Direction : Read the following passages and choose the best answer for each item.
The common cold probably causes more misery to more people than any other viral infection. Researchers have now found that it is possible to stop the spread of colds – at least within families.
Several recent studies have shown that alpha 2 interferon sprayed into the nose protects against colds, especially those caused by a class of viruses called rhinoviruses. Unfortunately, after a couple of weeks the treatment also causes many people’s noses to become dry, stuffy and bloody.
In a new clinical trial, researchers led by Robert Douglas at the University of Adelaide, and Frederick Hayden and his colleagues at the University of Virginia, found that spraying interferon into the nose once a day for a week could keep colds away in the short time, with only an occasional case of mild nasal bleeding.
Both groups of researchers tested the spray on the people most vulnerable to catching colds-those living with someone who had just come down with an infection. The Australian group found that only 14 percent of the interferon users showed cold symptoms. This result was confirmed by testing patients’ nose and throat swabs for the presence of virus. The American researchers found that only 7 percent of people treated with interferon fell ill during the trial period, but 35 percent of people using placebos became ill.
To find out how long the protection lasts, they assessed the incidence of colds in the two weeks following treatment. Only 1.3 percent of the people who used the drug developed colds that could be confirmed in laboratory. Fifteen percent of those on placebos succumbed.
What did the researchers do to find out how long protection from colds lasts?
a.They counted the number of patients catching colds after the study.
b.They continued treatment for two weeks after a cold.
c.They are more placebos to the patients for another two weeks.
d.They counted the number of days that people showed cold symptoms. ตอบ a
6)Direction : Read the following passages and choose the best answer for each item.
The common cold probably causes more misery to more people than any other viral infection. Researchers have now found that it is possible to stop the spread of colds – at least within families.
Several recent studies have shown that alpha 2 interferon sprayed into the nose protects against colds, especially those caused by a class of viruses called rhinoviruses. Unfortunately, after a couple of weeks the treatment also causes many people’s noses to become dry, stuffy and bloody.
In a new clinical trial, researchers led by Robert Douglas at the University of Adelaide, and Frederick Hayden and his colleagues at the University of Virginia, found that spraying interferon into the nose once a day for a week could keep colds away in the short time, with only an occasional case of mild nasal bleeding.
Both groups of researchers tested the spray on the people most vulnerable to catching colds-those living with someone who had just come down with an infection. The Australian group found that only 14 percent of the interferon users showed cold symptoms. This result was confirmed by testing patients’ nose and throat swabs for the presence of virus. The American researchers found that only 7 percent of people treated with interferon fell ill during the trial period, but 35 percent of people using placebos became ill.
To find out how long the protection lasts, they assessed the incidence of colds in the two weeks following treatment. Only 1.3 percent of the people who used the drug developed colds that could be confirmed in laboratory. Fifteen percent of those on placebos succumbed.
The word 'succumbed' here means ………
a.looked cold
b.became ill
c.seemed tense
d.remained weak ตอบ b
7)Directi
a.Many ชนิดของไวรัสอาจทำให้เกิดการ colds ทั่วไป b.Interferon ทำให้ประชาชน noses เป็นอบอ้าว c.Interferon มีศักยภาพสูงในการป้องกันการ colds d.Common colds ทำให้เกิดทุกข์มากกว่าโรคอื่น ๆตอบ dทิศทางที่ 2): อ่านทางเดินต่อไปนี้ และเลือกคำตอบที่ดีที่สุดสำหรับแต่ละรายการ เย็นทั่วไปทำให้เกิดทุกข์เพิ่มเติมกับคนมากกว่าเชื้อไวรัสอื่น ๆ อาจ นักวิจัยขณะนี้พบว่า จะสามารถหยุดการแพร่กระจายของ colds – น้อยภายในครอบครัว หลายการศึกษาล่าสุดได้แสดงว่า อินเตอร์ฟีรอนอัลฟา 2 พ่นเข้าจมูกป้องกันการ colds โดยเฉพาะเกิดจากชั้นของไวรัส rhinoviruses เรียก อับ หลังจากสองสัปดาห์ การรักษายังทำให้ noses หลายคน เป็นแห้ง คัดเลือด ในการทดลองทางคลินิกแบบใหม่ นักวิจัยนำ โดยโรเบิร์ตดักลาสที่มหาวิทยาลัยอเด และ เฮย์เดนเฟรเดอริก และเพื่อนร่วมงานของเขาที่มหาวิทยาลัยเวอร์จิเนีย พบอินเตอร์เฟียรอนที่ spraying เข้าจมูกเมื่อวันสัปดาห์สามารถเก็บ colds ไปในเวลาอันสั้น มีเฉพาะกรณีเป็นครั้งคราวของอ่อนเลือดโพรงจมูก Both groups of researchers tested the spray on the people most vulnerable to catching colds-those living with someone who had just come down with an infection. The Australian group found that only 14 percent of the interferon users showed cold symptoms. This result was confirmed by testing patients’ nose and throat swabs for the presence of virus. The American researchers found that only 7 percent of people treated with interferon fell ill during the trial period, but 35 percent of people using placebos became ill. To find out how long the protection lasts, they assessed the incidence of colds in the two weeks following treatment. Only 1.3 percent of the people who used the drug developed colds that could be confirmed in laboratory. Fifteen percent of those on placebos succumbed.Interferon is made in the form of a …………….a.pill b.creamc.liquid d.powder ตอบ c3)Direction : Read the following passages and choose the best answer for each item. The common cold probably causes more misery to more people than any other viral infection. Researchers have now found that it is possible to stop the spread of colds – at least within families. Several recent studies have shown that alpha 2 interferon sprayed into the nose protects against colds, especially those caused by a class of viruses called rhinoviruses. Unfortunately, after a couple of weeks the treatment also causes many people’s noses to become dry, stuffy and bloody. ในการทดลองทางคลินิกแบบใหม่ นักวิจัยนำ โดยโรเบิร์ตดักลาสที่มหาวิทยาลัยอเด และ เฮย์เดนเฟรเดอริก และเพื่อนร่วมงานของเขาที่มหาวิทยาลัยเวอร์จิเนีย พบอินเตอร์เฟียรอนที่ spraying เข้าจมูกเมื่อวันสัปดาห์สามารถเก็บ colds ไปในเวลาอันสั้น มีเฉพาะกรณีเป็นครั้งคราวของอ่อนเลือดโพรงจมูก ทั้งกลุ่มวิจัยทดสอบสเปรย์ในคนที่เสี่ยงที่สุดที่จะจับ colds-อาศัยอยู่กับคนที่เพิ่งมาลงกับการติดเชื้อ กลุ่มออสเตรเลียพบว่า เพียงร้อยละ 14 ของผู้ใช้อินเตอร์เฟียรอนพบอาการเย็น ผลนี้ได้รับการยืนยัน โดยการทดสอบผู้ป่วยจมูกและคอ swabs สำหรับสถานะของไวรัส นักวิจัยอเมริกันพบว่า เพียงร้อยละ 7 คนรับอินเตอร์เฟียรอนล้มป่วยในระหว่างระยะเวลาทดลองใช้ แต่ 35 เปอร์เซ็นต์ของคนที่ใช้ placebos กลายเป็นป่วย เพื่อหาระยะเวลาการป้องกัน พวกเขาประเมินอุบัติการณ์ของ colds ในสองสัปดาห์หลังการรักษา เพียงร้อยละ 1.3 ของคนที่ใช้ยาเสพติดพัฒนา colds ที่สามารถยืนยันในห้องปฏิบัติการ ร้อยละสิบห้าของ placebos ผู้ยอมจำนนต่อข้อเสียของการใช้อินเตอร์เฟียรอนคืออะไรa.It ทำให้จมูกของผู้ป่วยจะมีเลือดออกb.It ผลติดเชื้อร้ายแรงc.It ระคายเคืองจมูกและปากของผู้ใช้d.It นำไปสู่โรคอื่น ๆ ของจมูก ตอบ dทิศทาง 4): อ่านทางเดินต่อไปนี้ และเลือกคำตอบที่ดีที่สุดสำหรับแต่ละรายการ เย็นทั่วไปทำให้เกิดทุกข์เพิ่มเติมกับคนมากกว่าเชื้อไวรัสอื่น ๆ อาจ นักวิจัยขณะนี้พบว่า จะสามารถหยุดการแพร่กระจายของ colds – น้อยภายในครอบครัว หลายการศึกษาล่าสุดได้แสดงว่า อินเตอร์ฟีรอนอัลฟา 2 พ่นเข้าจมูกป้องกันการ colds โดยเฉพาะเกิดจากชั้นของไวรัส rhinoviruses เรียก อับ หลังจากสองสัปดาห์ การรักษายังทำให้ noses หลายคน เป็นแห้ง คัดเลือด ในการทดลองทางคลินิกแบบใหม่ นักวิจัยนำ โดยโรเบิร์ตดักลาสที่มหาวิทยาลัยอเด และ เฮย์เดนเฟรเดอริก และเพื่อนร่วมงานของเขาที่มหาวิทยาลัยเวอร์จิเนีย พบอินเตอร์เฟียรอนที่ spraying เข้าจมูกเมื่อวันสัปดาห์สามารถเก็บ colds ไปในเวลาอันสั้น มีเฉพาะกรณีเป็นครั้งคราวของอ่อนเลือดโพรงจมูก ทั้งกลุ่มวิจัยทดสอบสเปรย์ในคนที่เสี่ยงที่สุดที่จะจับ colds-อาศัยอยู่กับคนที่เพิ่งมาลงกับการติดเชื้อ กลุ่มออสเตรเลียพบว่า เพียงร้อยละ 14 ของผู้ใช้อินเตอร์เฟียรอนพบอาการเย็น ผลนี้ได้รับการยืนยัน โดยการทดสอบผู้ป่วยจมูกและคอ swabs สำหรับสถานะของไวรัส นักวิจัยอเมริกันพบว่า เพียงร้อยละ 7 คนรับอินเตอร์เฟียรอนล้มป่วยในระหว่างระยะเวลาทดลองใช้ แต่ 35 เปอร์เซ็นต์ของคนที่ใช้ placebos กลายเป็นป่วย To find out how long the protection lasts, they assessed the incidence of colds in the two weeks following treatment. Only 1.3 percent of the people who used the drug developed colds that could be confirmed in laboratory. Fifteen percent of those on placebos succumbed.From the studies, the number of people catching colds in the Australian group is …….a.one-third of that in the American groupb.as great as that in the American groupc.much less than that in the American groupd.twice as great as that in the American group ตอบ d5)Direction : Read the following passages and choose the best answer for each item. The common cold probably causes more misery to more people than any other viral infection. Researchers have now found that it is possible to stop the spread of colds – at least within families. Several recent studies have shown that alpha 2 interferon sprayed into the nose protects against colds, especially those caused by a class of viruses called rhinoviruses. Unfortunately, after a couple of weeks the treatment also causes many people’s noses to become dry, stuffy and bloody. In a new clinical trial, researchers led by Robert Douglas at the University of Adelaide, and Frederick Hayden and his colleagues at the University of Virginia, found that spraying interferon into the nose once a day for a week could keep colds away in the short time, with only an occasional case of mild nasal bleeding. Both groups of researchers tested the spray on the people most vulnerable to catching colds-those living with someone who had just come down with an infection. The Australian group found that only 14 percent of the interferon users showed cold symptoms. This result was confirmed by testing patients’ nose and throat swabs for the presence of virus. The American researchers found that only 7 percent of people treated with interferon fell ill during the trial period, but 35 percent of people using placebos became ill. To find out how long the protection lasts, they assessed the incidence of colds in the two weeks following treatment. Only 1.3 percent of the people who used the drug developed colds that could be confirmed in laboratory. Fifteen percent of those on placebos succumbed.What did the researchers do to find out how long protection from colds lasts?a.They counted the number of patients catching colds after the study.b.They continued treatment for two weeks after a cold.c.They are more placebos to the patients for another two weeks. d.They counted the number of days that people showed cold symptoms. ตอบ a6)Direction : Read the following passages and choose the best answer for each item. The common cold probably causes more misery to more people than any other viral infection. Researchers have now found that it is possible to stop the spread of colds – at least within families. Several recent studies have shown that alpha 2 interferon sprayed into the nose protects against colds, especially those caused by a class of viruses called rhinoviruses. Unfortunately, after a couple of weeks the treatment also causes many people’s noses to become dry, stuffy and bloody. In a new clinical trial, researchers led by Robert Douglas at the University of Adelaide, and Frederick Hayden and his colleagues at the University of Virginia, found that spraying interferon into the nose once a day for a week could keep colds away in the short time, with only an occasional case of mild nasal bleeding. Both groups of researchers tested the spray on the people most vulnerable to catching colds-those living with someone who had just come down with an infection. The Australian group found that only 14 percent of the interferon users showed cold symptoms. This result was confirmed by testing patients’ nose and throat swabs for the presence of virus. The American researchers found that only 7 percent of people treated with interferon fell ill during the trial period, but 35 percent of people using placebos became ill. To find out how long the protection lasts, they assessed the incidence of colds in the two weeks following treatment. Only 1.3 percent of the people who used the drug developed colds that could be confirmed in laboratory. Fifteen percent of those on placebos succumbed.The word 'succumbed' here means ……… a.looked coldb.became illc.seemed tensed.remained weak ตอบ b7)Directi
การแปล กรุณารอสักครู่..